# FDA recall D-0653-2020

> **AuroMedics Pharma LLC** · Class II · drug recall initiated 2019-11-19.

## Product

Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99

## Reason for recall

Presence of Foreign Tablets/Capsules: One  Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0653-2020
- **Recalling firm:** AuroMedics Pharma LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-11-19
- **Report date:** 2019-12-25
- **Termination date:** 2023-04-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Windsor, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0653-2020

## Citation

> AI Analytics. FDA recall D-0653-2020. Retrieved 2026-06-01 from https://api.ai-analytics.org/recall/D-0653-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*